35+ years in history. Veteran of 2 early stage MedTech ventures w/successful exits. Hands-on leader with strong general management, sales & marketing, international, new products clinical trial and regulatory affairs experience. Successfully obtained 2 FDA PMA & 1 CE mark approvals. Lead cash investor in Endomedix.

Solid development experience, led creation of new patented chemistry. Developed breakthrough techniques for biopolymer processing. Lead inventor on patents & author of ground breaking scientific publications. Effective at leading & coordinating world class team of subject matter experts in fields of biopolymer design, chemical engineering, chemometrics.

World renown polymer expert. Past chair, Polymeric Materials, Science & Engineering Division of American Chemical Society; Editor of "Polymers for Advanced Technologies, 1989-2001. Thomas Alva Edison Patent Award - 1995, 2011; North American Thermal Analysis Society Lifetime Achievement Award - 2010; Fellow-American Association for the Advancement of Science - 1993

Allied Signal Inc. -Research, Advanced Molecular Modeling and Computational Chemistry Applications; Group Leader-Nuclear Magnetic Resonance; High Performance Computing.
Hoechst Research and Technology-Scientist, NMR Spectroscopy
Yale University, Department of Chemistry-Assistant Professor of Chemistry
BA, Chemistry-Northwestern University; PhD & MS-Organic Chemistry-Columbia University; NIH Post Doctoral Fellow-California Institute of Technology.

Ret: Sr Corp VP-R&D, Pall Corporation. Key member of Pall Medical Business Unit launched platform of successful blood filtration products aimed at removing white blood cells from transfused blood. Co-inventor on 100+ issued and Published US and International patents, as well as a number of peer-reviewed scientific publications.
BS Chemistry-SUNY Albany; MS Polymer Chemistry-Florida State University; PhD Polymer Sciences - Polytechnic University.

More than 10 years of CFO Experience, including Fund Raising. Negotiated $1B exit for family business and managed two corporate acquisitions via merger. Leads due diligence for private investment group. Investor in Life Sciences early-stage companies.